Apella Capital, LLC Abbott Laboratories Transaction History
Apella Capital, LLC
- $2.41 Billion
- Q3 2024
A detailed history of Apella Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Apella Capital, LLC holds 6,191 shares of ABT stock, worth $713,822. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,191
Previous 6,006
3.08%
Holding current value
$713,822
Previous $624,000
12.98%
% of portfolio
0.03%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding ABT
# of Institutions
3,181Shares Held
1.33BCall Options Held
8.62MPut Options Held
7.18M-
Vanguard Group Inc Valley Forge, PA166MShares$19.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.58 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.28 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.6 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $202B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...